Page last updated: 2024-08-21

oxazoles and Tuberculosis, Drug-Resistant

oxazoles has been researched along with Tuberculosis, Drug-Resistant in 141 studies

Research

Studies (141)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (0.71)	29.6817
2010's	99 (70.21)	24.3611
2020's	41 (29.08)	2.80

Authors

Authors	Studies
Campino, S; Clark, TG; Gomes, P; Gómez-González, PJ; Hibberd, ML; Napier, G; Perdigao, J; Phelan, JE; Portugal, I; Puyen, ZM; Santos-Lazaro, D; Viveiros, M	1
Hafkin, J; Karlsson, MO; Mallikaarjun, S; Sasaki, T; Svensson, EM; Wang, X; Wang, Y	1
Adenov, M; Adnan, S; Ahmed, S; Bastard, M; Coutisson, S; Danielyan, N; Franke, MF; Hewison, C; Huerga, H; Islam, S; Janmohamed, A; Kamene Kimenye, M; Karakozian, H; Khan, P; Khan, U; Kholikulov, B; Kirakosyan, O; Krisnanda, A; Kumsa, A; Lachenal, N; Leblanc, G; Lecca, L; Mamsa, S; Melikyan, N; Mitnick, CD; Nkuebe, M; Osso, E; Padayachee, S; Rich, ML; Seung, KJ; Thit, P; Varaine, F	1
Bax, HI; De Steenwinkel, JEM; Lenaerts, A; Mudde, SE; Upton, AM	1
Antony, S; Bodhanwala, M; Jaiswal, A; Parmar, M; Sachdeva, KS; Salve, J; Shah, D; Shah, I; Tipre, P	1
Ahmed, S; Bastard, M; Franke, MF; Grium Tefera, D; Hewison, C; Holtzman, D; Huerga, H; Islam, S; Jacques Leblanc, G; Khan, PY; Khan, U; Kumsa, A; Lachenal, N; Leonovich, O; Mamsa, S; Manzur-Ul-Alam, M; Melikyan, N; Mitnick, CD; Myint, Z; Osso, E; Padayachee, S; Rafi Siddiqui, M; Rashitov, M; Rich, ML; Salahuddin, N; Salia, G; Sánchez, E; Serobyan, A; Seung, KJ; Varaine, F; Vetushko, D; Yeghiazaryan, L	1
Akkerman, O; Al-Abri, S; Alffenaar, JW; Amini, S; Arabpour, E; Centis, R; Chakaya, J; D'Ambrosio, L; Dalcolmo, MP; Denholm, JT; Khalili, F; Kurhasani, X; Migliori, GB; Muňoz-Torrico, M; Nasiri, MJ; Pontali, E; Saderi, L; Schaaf, HS; Seaworth, B; Silva, DR; Sotgiu, G; Tiberi, S; van den Boom, M; Zangiabadian, M; Zumla, A	1
De Leon, A; Frias, M; Garcia-Prats, AJ; Gler, MT; Hafkin, J; Hesseling, AC; Malikaarjun, S; Schaaf, HS; van der Laan, L	1
Alsalhani, A; Athersuch, K; Elder, G; Martin, M; Perrin, C	1
De Los Rios, J; Diacon, AH; Dooley, KE; Karlsson, MO; Maartens, G; Shenje, J; Svensson, EM; Tanneau, L; Upton, CM; Wiesner, L	1
Bin, W; Chen, S; Ding, CZ; Franzblau, SG; Hu, Y; Huang, Z; Jiang, N; Luo, W; Shen, L; Tao, X; Wei, X; Wei, Y; Xu, D; Yang, M; Zhu, Y	1
Apolisi, I; Beko, B; Cengani, L; Cox, H; Daniels, J; Fatshe, S; Furin, J; Gumede, N; Joseph, K; Mathee, S; Maugans, C; Memani, B; Reuter, A; Tyeku, N	1
Andersen, ÅB; Dahl, VN; Guglielmetti, L; Holmgaard, FB; Lillebaek, T; Wejse, C	1
Millard, J; Nimmo, C; O'Donnell, M; Rimmer, S	1
Alghamdi, WA; Alshaer, MH; Avaliani, Z; Barbakadze, K; Benkeser, D; Blumberg, HM; Jin, Y; Kempker, RR; Kipiani, M; Maranchick, NF; Mikiashvili, L; Peloquin, CA	1
Atwood, S; Bastard, M; Franke, MF; Hewison, C; Huerga, H; Khan, AJ; Khan, PY; Khan, U; Mitnick, CD; Rich, M; Seung, KJ; Varaine, F	1
Dheda, K; Dooley, KE; Furin, J; Gumbo, T; Maartens, G; Murray, M; Nardell, EA; Warren, RM	1
Dheda, K; Esmail, A; Limberis, J; Olayanju, O	1
Ahmed, S; Aiylchiev, S; Alam, M; Bastard, M; Docteur, W; Franke, MF; Gottlieb, G; Hewison, C; Huerga, H; Islam, S; Khachatryan, N; Khan, P; Khan, U; Kotrikadze, T; Kumsa, A; Lecca, L; Melikyan, N; Mitnick, CD; Naing, YY; Oyewusi, L; Putri, FA; Rich, M; Seung, KJ; Tassew, YM; Wanjala, S; Yedilbayev, A	1
Avaliani, Z; Bablishvili, N; Barbakadze, K; Benkeser, D; Blumberg, HM; Kempker, RR; Kipiani, M; Mikiashvili, L; Peloquin, CA; Zhao, Y	1
Farhat, M; Kadura, S; King, N; Köser, CU; Nakhoul, M; Theron, G; Zhu, H	1
Alffenaar, JC; Anthony, RM; Bañuls, AL; Cao, TTH; Nguyen, NV; Nguyen, TVA; Nguyen, VAT; Vu, DH	1
Jeon, D; Jo, KW; Kang, H; Lee, HH; Shim, TS; Yim, JJ	1
Ader, F; Chiesi, S; Dominguez, J; Eimer, J; Guglielmetti, L; Masini, T; Robert, J; Varaine, F; Veziris, N	1
Beko, B; Cox, H; Daniels, J; De Avezedo, V; Ferlazzo, G; Furin, J; Hughes, J; Isaakidis, P; Kock, Y; Makhanda, G; Mohr-Holland, E; Reuter, A; Trivino Duran, L	1
Aono, A; Kato, S; Mitarai, S; Ohta, K; Okumura, M; Takaki, A; Yoshiyama, T	1
Mathema, B; O'Donnell, M	1
Avihingsanon, A; Borrell, S; Böttger, EC; Collantes, J; Egger, M; Fenner, L; Gagneux, S; Hömke, R; Keller, PM; Loiseau, C; Reichmuth, ML; Reinhard, M; Sander, P; Wilkinson, RJ; Yotebieng, M; Zürcher, K	1
Alikhanova, N; Barbova, A; Battaglia, S; Cabibbe, AM; Cirillo, DM; Dean, AS; Groenheit, R; Ismail, N; Meehan, CJ; Mostofa Kamal, SM; Niemann, S; Rigouts, L; Skrahina, A; Spitaleri, A; Tahseen, S; Utpatel, C; Zignol, M	1
Chen, M; Jiang, W; Jiang, X; Li, D; Li, Y; Lin, Y; Liu, C; Si, S; Xu, Y; You, X; Zhang, J	1
Coutisson, S; Dalal, A; Das, M; Ferlazzo, G; Hossain, FN; Isaakidis, P; Kalon, S; Lachenal, N; Laxmeshwar, C; Mamnoon, F; Mansoor, H; Mathur, T; Meneguim, AC; Paryani, R; Ravi, S; Singh, P	1
Jeon, D; Kang, H; Kwon, YS; Shim, TS; Yim, JJ	1
Gibiansky, E; Mallikaarjun, S; Wang, X	1
Breitscheidel, L; Ghosh, S; Hafkin, J; Hittel, N; Lazarevic, N; Martin, A	1
Al-Shaer, MH; Alghamdi, WA; Barbakadze, K; Kempker, RR; Kipiani, M; Mikiashvili, L; Peloquin, CA	1
Comins, K; Conradie, F; Cramer, YS; De Los Rios, J; Diacon, AH; Donahue, K; Dooley, KE; Hafner, R; Lama, JR; Maartens, G; Moran, L; Morganroth, J; Rosenkranz, SL; Shenje, J; von Groote-Bidlingmaier, F	1
Acharya, S; Chavan, V; Das, M; Dhakulkar, S; Ferlazzo, G; Isaakidis, P; Iyer, A; Kalon, S; Mansoor, H; Meneguim, AC; Oswal, V; Ravi, S; Rebello, L; Shah, D; Sutar, N; Thakur, HP; Vengurlekar, D	1
Bacchetti, P; Dheda, K; Esmail, A; Gandhi, M; Gerona, R; Huo, S; Metcalfe, J; Reckers, A	1
Adenov, MM; Algozhin, YZ; Berikova, EA; Issayeva, AM; Maretbayeva, SM; Rakisheva, AS; Rich, ML; Seung, KJ; Stambekova, AT; Yedilbayev, A; Yeraliyeva, LT	1
Hwang, H; Jeon, D; Kang, H; Kwon, YS; Shim, TS; Yim, JJ	1
Acquah, R; Daniels, J; Furin, J; Loveday, M; Mohr-Holland, E; Mudaly, V; Reuter, A	1
Mondoni, M; Saderi, L; Sotgiu, G	1
Gupta, R; Hafkin, J; Hittel, N; Martin, A	2
Avaliani, Z; Ferlazzo, G; Hayrapetyan, A; Hewison, C; Jonckheere, S; Khaidarkhanova, Z; Lachenal, N; Mohr, E; Sinha, A; Skrahina, A; Vambe, D; Varaine, F; Vasilyeva, I	1
Jo, KW; Nam, GB; Shim, TS; Yoon, HY	1
Kabra, SK; Lodha, R; Mukherjee, A	1
Chang, KC; Cox, H; Dheda, K; Esmail, A; Lange, C; Wasserman, S	1
Cox, V; Furin, J; Lessem, E	1
Dowdy, D; Merritt, MW; Taylor, H; von Delft, A; Zwerling, A	1
Cox, H; Cox, V; Ditiu, L; Furin, J; Garcia-Prats, A; Koenig, S; Lessem, E; Nathavitharana, R; Reuter, A; Seddon, JA; Stillo, J; Tisile, P; von Delft, A; von Delft, D	1
Hwang, SH; Jeon, D; Kang, B; Kang, H; Koh, WJ; Lee, T; Mok, J; Park, JS; Yim, JJ	1
Barkane, L; Gupta, R; Hittel, N; Kuksa, L	1
Aarti, C; Barbabosa-Pliego, A; Khusro, A; Salem, AZM	1
Cox, V; Furin, J	1
Barkane, L; Caumes, E; Fréchet-Jachym, M; Guglielmetti, L; Kuksa, L; Le Dû, D; Marigot-Outtandy, D; Robert, J; Veziris, N; Yazdanpanah, Y	1
Migliori, GB; Tadolini, M; Tiberi, S	1
Cox, H; De Avezedo, V; Egazaryan, L; Ferlazzo, G; Furin, J; Hewison, C; Hughes, J; Isaakidis, P; Jonckheere, S; Kalon, S; Khachatryan, N; Laxmeshwar, C; Mohr, E; Shroufi, A	1
Centis, R; D'Ambrosio, L; Migliori, GB; Pontali, E; Spanevello, A; Visca, D	1
Hun Choe, Y; Kim, CT; Kim, HR; Kim, TO; Ko, YC; Kwon, YS; Shin, HJ	1
Uplekar, M	1
Brigden, G; Cox, V; Crespo, RH; Furin, J; Lessem, E; Lynch, S; Rich, ML; Waning, B	1
Falzon, D; Halleux, CM; Jaramillo, E; Merle, C; Mirzayev, F; Olliaro, P; Weyer, K	1
Hauser, J; Jaramillo, E; Kuwana, R; Masini, T; Nhat Linh, N	1
Chang, KC; Chau, CH; Lam, FM; Law, WS; Lee, SN; Leung, CC; Leung, EC; Leung, WM; Mok, TY; Tai, LB; Yew, WW	1
Ade, S; Alikhanova, N; Benedetti, G; Cox, H; Daniels, J; De Azevedo, V; Edwards, J; Ferlazzo, G; Furin, J; Hughes, J; Isaakidis, P; Kock, Y; Mohr, E; Reuter, A; Shroufi, A; Steele, SJ; Trivino Duran, L	1
Bothamley, G; Burman, M; Guglielmetti, L; Kunst, H; Lange, C; Tiberi, S; Togonidze, T; Wejse, C	1
Centis, R; D'Ambrosio, L; Migliori, GB; Pontali, E; Sotgiu, G; Spanevello, A; Tadolini, M; Tiberi, S; Visca, D	1
Borroni, E; Cirillo, DM; Crook, DW; Cugnata, F; Davies, TJ; Fowler, PW; Gibertoni Cruz, AL; Grazian, C; Hoosdally, SJ; Peto, TEA; Rancoita, PMV; Walker, TM	1
Choi, H; Kim, KJ; Lee, SH; Yang, JS	1
Perdigão, J; Portugal, I	1
Fan, Q; Ming, WK; Yip, WY; You, JHS	1
Li, Y; Sun, F; Zhang, W	1
Centis, R; Migliori, GB; Sotgiu, G	1
Balanag, V; Bielskiene, V; Cadena, E; Caoili, J; Cirule, A; Danilovits, M; Davidaviciene, E; Domente, L; Geiter, LJ; Gupta, R; Hafkin, J; Hittel, N; Lizarbe, V; Patientia, R; Petersen, C; Sanchez, E; Segura, P; Staples, S; Ticona, E; Variava, E; von Groote-Bidlingmaier, F; Wells, C; Yu, C	1
Ahn, H; Ahn, JH; Cho, SN; Hahn, S; Jang, JY; Jeon, D; Jhun, BW; Jo, KW; Kang, YA; Kim, CK; Kim, DK; Kim, JS; Kim, SY; Kim, YR; Koh, WJ; Lee, JH; Lee, JY; Lee, M; Lee, SH; Lee, T; Mok, J; Park, JS; Shim, TS; Shin, S; Shin, SJ; Song, T; Won, HJ; Yim, JJ	1
Arora, VK; Chopra, KK	1
Khalid, UK; Mathuria, KK; Munjal, SK; Myneedu, VP; Puri, MM; Sarin, R; Singla, N; Singla, R; Verma, A; Vohra, V	1
Cox, H; Furin, J; Loveday, M; Reuter, A; Seddon, JA	1
Akkerman, O; Al-Marzouqi, NH; Aleksa, A; Alffenaar, JW; Arias-Guillén, M; Belilovski, E; Bernal, E; Boeree, MJ; Borisov, SE; Bruchfeld, J; Cadiñanos Loidi, J; Cai, Q; Caminero, JA; Cebrian Gallardo, JJ; Centis, R; Codecasa, LR; D'Ambrosio, L; Dalcolmo, M; Danila, E; Dara, M; Davidavičienė, E; Davies Forsman, L; De Los Rios Jefe, J; Denholm, J; Duarte, R; Elamin, SE; Ferrarese, M; Filippov, A; Ganatra, S; Garcia, A; García-García, JM; Gayoso, R; Giraldo Montoya, AM; Gomez Rosso, RG; Gualano, G; Hoefsloot, W; Ilievska-Poposka, B; Jonsson, J; Khimova, E; Kuksa, L; Kunst, H; Laniado-Laborín, R; Li, Y; Magis-Escurra, C; Manfrin, V; Manga, S; Marchese, V; Martínez Robles, E; Maryandyshev, A; Matteelli, A; Migliori, GB; Mullerpattan, JB; Munoz-Torrico, M; Mustafa Hamdan, H; Nieto Marcos, M; Noordin, NM; Palmero, DJ; Palmieri, F; Payen, MC; Piubello, A; Pontali, E; Pontarelli, A; Quirós, S; Rendon, A; Skrahina, A; Šmite, A; Solovic, I; Sotgiu, G; Souleymane, MB; Spanevello, A; Stošić, M; Tadolini, M; Tiberi, S; Udwadia, ZF; van den Boom, M; Vescovo, M; Viggiani, P; Visca, D; Zhurkin, D; Zignol, M	1
De Azevedo, V; Ferlazzo, G; Hewison, C; Isaakidis, P; Mohr, E	1
Bethunaickan, R; Chandramohan, Y; Padmanaban, V; Ranganathan, UD; Swaminathan, S; Tripathy, S	1
Jeon, D; Jhun, BW; Kang, B; Kang, H; Koh, WJ; Kwak, N; Lee, T; Mok, J; Yim, JJ	1
Sharma, S	1
Karekar, SR; Marathe, PA	1
Caoili, JC; Chawla, P; Dartois, V; Dooley, KE; Ganatra, S; Gler, MT; Jain, SK; Peloquin, CA; Pieterse, L; Ritchie, B; Tornheim, JA; Tucker, EW; Udwadia, ZF; Zimmerman, MD	1
Schaberg, T	1
Liu, Y; Sha, W; Tang, S; Xiao, H; Zhang, Q	1
Boechat, N; Branco, FS; Pinto, AC	1
Balasegaram, M; Brigden, G; du Cros, P; Horsburgh, CR; Hughes, J; McIlleron, H; Mitnick, CD; Nuermberger, E; Nyang'wa, BT; Phillips, PP; Rich, M; Varaine, F	1
Jeong, BH; Koh, WJ; Kwon, YS	2
Lo, JH; Ryan, NJ	1
Blair, HA; Scott, LJ	1
Chang, KC; Heyckendorf, J; Lange, C; Olaru, ID; von Groote-Bidlingmaier, F; Yew, WW	1
Centis, R; D'ambrosio, L; Migliori, GB; Sotgiu, G	1
Lynch, JB; Szumowski, JD	1
Geiter, LJ; Gupta, R; Hittel, N; Wells, CD	1
Abubakar, I; Brown, NM; Burman, WJ; Ellington, MJ; Feuerriegel, S; Ismail, NA; Javid, B; Köser, CU; Liddell, K; Moore, D; Niemann, S; Peacock, SJ; Török, ME	1
Chopra, S; Dasgupta, A; Soni, I; Thakare, R	1
Cox, H; Daniels, C; Furin, J; Lessem, E; McKenna, L; Mitnick, CD; Mosidi, T; Reed, C; Seaworth, B; Stillo, J; Tisile, P; von Delft, D	1
Diel, R; Hittel, N; Schaberg, T	1
Bloemberg, GV; Böttger, EC; Hömke, R; Keller, PM; Ritter, C; Valsesia, G	1
Bianchini, S; Blasi, F; Esposito, S	1
Caminero, JA; Scardigli, A	1
Centis, R; D'Ambrosio, L; Migliori, GB; Pontali, E; Sotgiu, G; Spanevello, A	1
Diel, R; Gibbert, J; Wirth, D; Wolfson, LJ	1
Bloemberg, GV; Borrell, S; Böttger, EC; Coscolla, M; Feldmann, J; Gagneux, S; Hömke, R; Keller, PM; Latshang, T; Ritter, C; Rothe, T; Schulthess, B; Stucki, D; Stuckia, D; Trauner, A	1
Brigden, G; du Cros, P; Wong, S	1
Bastard, M; Bonnet, M; du Cros, P; Hayrapetyan, A; Hewison, C; Khamraev, A; Khurkhumal, S; Kimenye, K; Sanchez-Padilla, E; Telnov, A; Themba, D; Varaine, F	1
Dawson, A; Silva, DS; Upshur, RE	1
Nau, JY	1
Brigden, G; Furin, J; Lessem, E; Lynch, S; Rich, M; Vaughan, L	1
Ben Amor, Y; Sullivan, T	1
Awad, M; Cabrera-Rivero, JL; Cirule, A; Danilovits, M; Gao, M; Geiter, LJ; Gentry, LM; Gupta, R; Sanchez-Garavito, E; Tupasi, T; Vargas-Vasquez, DE; Wells, CD; Xiao, H	1
Hamasako, Y; Hashizume, K; Kashiyama, E; Ohzone, Y; Sasabe, H; Shibata, M; Shimokawa, Y; Umehara, K	1
Nguyen, L	1
Furin, J; Master, I	1
Abbadi, BL; Basso, LA; Campos, MM; de Souza, MV; Gonçalves, RS; González-Martín, J; López-Gavín, A; Rodrigues-Junior, VS; Santos, DS; Trindade, RV; Tudó, G; Villela, AD	1
Garcia-Prats, AJ; Hesseling, AC; Schaaf, HS; Thee, S; van der Laan, L	1
Byun, JH; Kang, HR; Lee, EK; Park, JA; Shin, JY	1
Baudin, E; Cellamare, M; Mitnick, CD; Trippa, L; Ventz, S	1
Wallis, RS	1
Centis, R; D'Ambrosio, L; Enwerem, M; Lingtsang, RD; Migliori, GB; Sadutshang, TD; Tadolini, M; Tiberi, S	1
Centis, R; D'Ambrosio, L; Fuentes, Z; Migliori, GB; Sotgiu, G; Tiberi, S; Zumla, A	1
Cooke, G; Fortunak, J; Gotham, D; Hill, A; Khoo, S; Nytko, FE; Pozniak, A	1
Centis, R; D'Ambrosio, L; Esposito, S; Migliori, GB; Pontali, E; Sotgiu, G; Tadolini, M; Tiberi, S	1
Sharma, DC	1
Brzezinski, A; Milstein, M; Mitnick, CD; Varaine, F	1
Geiter, LJ; Gupta, R; Hafkin, J; Hittel, N; Wells, CD	1
Dass, R; Hettle, R; Wirth, D	1
Awad, M; Cabrera-Rivero, JL; Chang, J; Danilovits, M; Gao, M; Geiter, LJ; Gler, MT; Koh, WJ; Kurve, A; Ogata, H; Park, SK; Sanchez-Garavito, E; Seaworth, B; Shim, TS; Skripconoka, V; Suh, GY; Suzuki, K; Tupasi, T; Vargas-Vasquez, DE; Wells, CD; Xiao, H	1
Chaisson, RE; Nuermberger, EL	1
Crunkhorn, S	1
Cirule, A; Danilovits, M; Geiter, LJ; Kummik, T; Kurve, A; Leimane, V; Levina, K; Manissero, D; Pehme, L; Skenders, G; Skripconoka, V; Tomson, T; Wells, CD	1
Centis, R; D'Ambrosio, L; Migliori, GB	1
Chai, SJ; Rao, CY; Varma, JK	1
Compton, C; Gheuens, J; Spigelman, M	1
Zhang, Y	1

Reviews

35 review(s) available for oxazoles and Tuberculosis, Drug-Resistant

Article	Year
Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022, Volume: 124 Suppl 1 Topics: Antitubercular Agents; Diarylquinolines; Humans; Nitroimidazoles; Oxazoles; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2022
Recently developed drugs for the treatment of drug-resistant tuberculosis: a research and development case study. BMJ global health, 2022, Volume: 7, Issue:4 Topics: Antitubercular Agents; Humans; Oxazoles; Research; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2022
Efficacy and Tolerability of Concomitant Use of Bedaquiline and Delamanid for Multidrug- and Extensively Drug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 04-03, Volume: 76, Issue:7 Topics: Antitubercular Agents; Diarylquinolines; Extensively Drug-Resistant Tuberculosis; Humans; Nitroimidazoles; Oxazoles; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2023
The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis. The Lancet. Respiratory medicine, 2019, Volume: 7, Issue:9 Topics: Antitubercular Agents; Diarylquinolines; Drug Therapy, Combination; Humans; Linezolid; Nitroimidazoles; Oxazoles; Periodicals as Topic; Pulmonary Medicine; Societies, Medical; Tuberculosis; Tuberculosis, Multidrug-Resistant	2019
Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid. The Journal of antimicrobial chemotherapy, 2020, 08-01, Volume: 75, Issue:8 Topics: Antitubercular Agents; Clofazimine; Diarylquinolines; Humans; Linezolid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Pharmaceutical Preparations; Tuberculosis, Multidrug-Resistant	2020
Delamanid Resistance: Update and Clinical Management. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 12-15, Volume: 71, Issue:12 Topics: Antitubercular Agents; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2020
Bedaquiline and delamanid for drug-resistant tuberculosis: a clinician's perspective. Future microbiology, 2020, Volume: 15 Topics: Antitubercular Agents; Child; Clinical Trials as Topic; Diarylquinolines; Drug Therapy, Combination; Female; Humans; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Pregnancy; Tuberculosis, Multidrug-Resistant	2020
Novel treatments in multidrug-resistant tuberculosis. Current opinion in pharmacology, 2021, Volume: 59 Topics: Antitubercular Agents; Drug Therapy, Combination; Humans; Oxazoles; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2021
Current therapies for the treatment of multidrug-resistant tuberculosis in children in India. Expert opinion on pharmacotherapy, 2017, Volume: 18, Issue:15 Topics: Antitubercular Agents; Child; Diarylquinolines; Drug Administration Schedule; Humans; India; Microbial Sensitivity Tests; Nitroimidazoles; Oxazoles; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2017
Recent controversies about MDR and XDR-TB: Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB? Respirology (Carlton, Vic.), 2018, Volume: 23, Issue:1 Topics: Antitubercular Agents; Diarylquinolines; Drug Administration Schedule; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Humans; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant; World Health Organization	2018
The devil we know: is the use of injectable agents for the treatment of MDR-TB justified? The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2017, 11-01, Volume: 21, Issue:11 Topics: Antitubercular Agents; Diarylquinolines; Health Services Accessibility; Human Rights; Humans; Injections; Nitroimidazoles; Oxazoles; Patient-Centered Care; Tuberculosis, Multidrug-Resistant	2017
Neoteric advancement in TB drugs and an overview on the anti-tubercular role of peptides through computational approaches. Microbial pathogenesis, 2018, Volume: 114 Topics: Antitubercular Agents; Computational Biology; Diarylquinolines; Drug Design; Extensively Drug-Resistant Tuberculosis; Humans; Models, Molecular; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Peptides; Tuberculosis; Tuberculosis, Multidrug-Resistant; World Health Organization	2018
Multi and extensively drug-resistant pulmonary tuberculosis: advances in diagnosis and management. Current opinion in pulmonary medicine, 2018, Volume: 24, Issue:3 Topics: Adolescent; Antitubercular Agents; Child; Diarylquinolines; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Humans; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2018
Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review. The European respiratory journal, 2018, Volume: 52, Issue:1 Topics: Antitubercular Agents; Diarylquinolines; Drug Therapy, Combination; Humans; Nitroimidazoles; Oxazoles; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2018
Genetics and roadblocks of drug resistant tuberculosis. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2019, Volume: 72 Topics: Antitubercular Agents; Diarylquinolines; Drug Resistance, Multiple, Bacterial; Epistasis, Genetic; Humans; Mutation; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Phylogeny; Tuberculosis, Multidrug-Resistant	2019
Bedaquiline and delamanid in the treatment of multidrug-resistant tuberculosis: Promising but challenging. Drug development research, 2019, Volume: 80, Issue:1 Topics: Animals; Antitubercular Agents; Clinical Trials as Topic; Diarylquinolines; Electrocardiography; Humans; Nitroimidazoles; Oxazoles; Retrospective Studies; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2019
[Tuberculosis: new treatment options and updated recommendations]. Deutsche medizinische Wochenschrift (1946), 2013, Volume: 138, Issue:14 Topics: Antitubercular Agents; Aza Compounds; Cross-Sectional Studies; Diagnosis, Differential; Diarylquinolines; Fluoroquinolones; Germany; Humans; Moxifloxacin; Nitroimidazoles; Oxazoles; Prognosis; Quinolines; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant	2013
An update on the chemistry and medicinal chemistry of novel antimycobacterial compounds. Current topics in medicinal chemistry, 2013, Volume: 13, Issue:22 Topics: Anti-HIV Agents; Antitubercular Agents; Clinical Trials as Topic; Diarylquinolines; Drug Design; Humans; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Structure-Activity Relationship; Tuberculosis, Multidrug-Resistant	2013
Tuberculosis: clinical trials and new drug regimens. Current opinion in pulmonary medicine, 2014, Volume: 20, Issue:3 Topics: Acetamides; Adamantane; Antitubercular Agents; Clinical Trials as Topic; Diarylquinolines; Drug Administration Schedule; Drug Design; Ethylenediamines; Female; Fluoroquinolones; Humans; Levofloxacin; Linezolid; Male; Moxifloxacin; Nitroimidazoles; Oxazoles; Oxazolidinones; Spiro Compounds; Thiazines; Tuberculosis; Tuberculosis, Multidrug-Resistant	2014
Delamanid: first global approval. Drugs, 2014, Volume: 74, Issue:9 Topics: Antitubercular Agents; Drug Approval; Humans; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2014
Delamanid when other anti-tuberculosis-treatment regimens failed due to resistance or tolerability. Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:2 Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2015
Delamanid: a review of its use in patients with multidrug-resistant tuberculosis. Drugs, 2015, Volume: 75, Issue:1 Topics: Antitubercular Agents; Humans; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2015
Novel drugs against tuberculosis: a clinician's perspective. The European respiratory journal, 2015, Volume: 45, Issue:4 Topics: Adamantane; Antitubercular Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Diarylquinolines; Drug Therapy, Combination; Ethylenediamines; Extensively Drug-Resistant Tuberculosis; Female; Follow-Up Studies; Humans; Male; Nitroimidazoles; Oxazoles; Oxazolidinones; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2015
Tuberculosis treatment and drug regimens. Cold Spring Harbor perspectives in medicine, 2015, Jan-08, Volume: 5, Issue:5 Topics: Antitubercular Agents; China; Diarylquinolines; Humans; India; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant; USSR	2015
Profile of delamanid for the treatment of multidrug-resistant tuberculosis. Drug design, development and therapy, 2015, Volume: 9 Topics: Animals; Antitubercular Agents; Drug Interactions; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Long QT Syndrome; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Risk Assessment; Risk Factors; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2015
Delamanid for the treatment of pulmonary multidrug-resistant tuberculosis. Drugs of today (Barcelona, Spain : 1998), 2015, Volume: 51, Issue:2 Topics: Antitubercular Agents; Drug Interactions; Humans; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2015
Access to new medications for the treatment of drug-resistant tuberculosis: patient, provider and community perspectives. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2015, Volume: 32 Topics: Antitubercular Agents; Compassionate Use Trials; Diarylquinolines; Health Services Accessibility; Humans; Linezolid; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant; Vulnerable Populations	2015
Bedaquiline and delamanid in tuberculosis. Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:15 Topics: Antitubercular Agents; Clinical Trials as Topic; Diarylquinolines; Drug Interactions; Drug Resistance, Bacterial; Humans; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2015
Management of drug resistantTB in patients with HIV co-infection. Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:18 Topics: Antitubercular Agents; Coinfection; Diarylquinolines; Disease Management; Extensively Drug-Resistant Tuberculosis; HIV Infections; Humans; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant; World Health Organization	2015
Antibiotic resistance mechanisms in M. tuberculosis: an update. Archives of toxicology, 2016, Volume: 90, Issue:7 Topics: Aminosalicylic Acid; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Folic Acid; Humans; Molecular Structure; Mycobacterium tuberculosis; Oxazoles; Pyrazinamide; Tuberculosis, Multidrug-Resistant	2016
Adverse effects of oral second-line antituberculosis drugs in children. Expert opinion on drug safety, 2016, Volume: 15, Issue:10 Topics: Age Factors; Antitubercular Agents; Child; Diarylquinolines; Dose-Response Relationship, Drug; HIV Infections; Humans; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2016
Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review. International journal of molecular sciences, 2017, Feb-07, Volume: 18, Issue:2 Topics: Antitubercular Agents; Diarylquinolines; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Humans; Nitroimidazoles; Oxazoles; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2017
(Re)moving the needle: prospects for all-oral treatment for multidrug-resistant tuberculosis. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2016, 12-01, Volume: 20, Issue:12 Topics: Administration, Oral; Antitubercular Agents; Clinical Trials, Phase III as Topic; Diarylquinolines; Evidence-Based Medicine; Humans; Linezolid; Needles; Nitroimidazoles; Oxazoles; Randomized Controlled Trials as Topic; Tuberculosis, Multidrug-Resistant	2016
Delamanid in the treatment of multidrug-resistant tuberculosis. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2016, 12-01, Volume: 20, Issue:12 Topics: Antitubercular Agents; Clinical Protocols; Clinical Trials, Phase III as Topic; Humans; Nitroimidazoles; Oxazoles; Randomized Controlled Trials as Topic; Tuberculosis, Multidrug-Resistant	2016
Advances in the treatment of tuberculosis. Clinical pharmacology and therapeutics, 2007, Volume: 82, Issue:5 Topics: Adamantane; AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Drugs, Investigational; Ethylenediamines; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Pyrazinamide; Rifampin; Treatment Refusal; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2007

Trials

8 trial(s) available for oxazoles and Tuberculosis, Drug-Resistant

Article	Year
Delamanid Added to an Optimized Background Regimen in Children with Multidrug-Resistant Tuberculosis: Results of a Phase I/II Clinical Trial. Antimicrobial agents and chemotherapy, 2022, 05-17, Volume: 66, Issue:5 Topics: Adult; Antitubercular Agents; Child; Child, Preschool; Female; Humans; Nitroimidazoles; Oxazoles; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2022
QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial. The Lancet. Infectious diseases, 2021, Volume: 21, Issue:7 Topics: Adult; Antitubercular Agents; Diarylquinolines; Drug Therapy, Combination; Electrocardiography; Female; Humans; Male; Nitroimidazoles; Oxazoles; Peru; Rifampin; South Africa; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2021
Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial. The Lancet. Respiratory medicine, 2019, Volume: 7, Issue:3 Topics: Antitubercular Agents; Double-Blind Method; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Nitroimidazoles; Oxazoles; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2019
Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, m Trials, 2019, Jan-16, Volume: 20, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Equivalence Trials as Topic; Female; Humans; Levofloxacin; Linezolid; Male; Middle Aged; Multicenter Studies as Topic; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Pyrazinamide; Republic of Korea; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult	2019
Clinical benefit of delamanid (OPC-67683) in the treatment of multidrug-resistant tuberculosis patients in China. Cell biochemistry and biophysics, 2013, Volume: 67, Issue:3 Topics: Adolescent; Adult; Antitubercular Agents; China; Double-Blind Method; Female; Humans; Male; Mental Disorders; Middle Aged; Nitroimidazoles; Oxazoles; Placebo Effect; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult	2013
Long-term mortality assessment of multidrug-resistant tuberculosis patients treated with delamanid. The European respiratory journal, 2015, Volume: 45, Issue:5 Topics: Biomarkers; Follow-Up Studies; Humans; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Prospective Studies; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2015
Building clinical trial capacity to develop a new treatment for multidrug-resistant tuberculosis. Bulletin of the World Health Organization, 2016, Feb-01, Volume: 94, Issue:2 Topics: Antitubercular Agents; Capacity Building; Clinical Protocols; Documentation; Drug Approval; Humans; International Cooperation; Nitroimidazoles; Oxazoles; Research Design; Tuberculosis, Multidrug-Resistant	2016
Delamanid for multidrug-resistant pulmonary tuberculosis. The New England journal of medicine, 2012, Jun-07, Volume: 366, Issue:23 Topics: Adolescent; Adult; Antitubercular Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Sputum; Survival Analysis; Tuberculosis, Multidrug-Resistant; Young Adult	2012

Other Studies

98 other study(ies) available for oxazoles and Tuberculosis, Drug-Resistant

Article	Year
Genetic diversity of candidate loci linked to Mycobacterium tuberculosis resistance to bedaquiline, delamanid and pretomanid. Scientific reports, 2021, 09-30, Volume: 11, Issue:1 Topics: Antitubercular Agents; Diarylquinolines; Drug Resistance, Multiple, Bacterial; Humans; Mutation; Mycobacterium smegmatis; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing	2021
Population Pharmacokinetic and Concentration-QTc Analysis of Delamanid in Pediatric Participants with Multidrug-Resistant Tuberculosis. Antimicrobial agents and chemotherapy, 2022, 02-15, Volume: 66, Issue:2 Topics: Adolescent; Adult; Antitubercular Agents; Child; Child, Preschool; Humans; Infant; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2022
Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 09-29, Volume: 75, Issue:6 Topics: Antitubercular Agents; Diarylquinolines; Electrolytes; Humans; Linezolid; Nitroimidazoles; Oxazoles; Prospective Studies; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2022
Delamanid or pretomanid? A Solomonic judgement! The Journal of antimicrobial chemotherapy, 2022, 03-31, Volume: 77, Issue:4 Topics: Antitubercular Agents; Diarylquinolines; Humans; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2022
Feasibility of a "Salvage Regimen" Using Home-based Intravenous Meropenem Therapy With a Delamanid/Bedaquilline Containing Regimen in the Management of MDR/XDR Pediatric Tuberculosis. The Pediatric infectious disease journal, 2022, 05-01, Volume: 41, Issue:5 Topics: Adolescent; Antitubercular Agents; Child; Extensively Drug-Resistant Tuberculosis; Feasibility Studies; Female; Humans; Male; Meropenem; Nitroimidazoles; Oxazoles; Retrospective Studies; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2022
Safety and Effectiveness Outcomes From a 14-Country Cohort of Patients With Multi-Drug Resistant Tuberculosis Treated Concomitantly With Bedaquiline, Delamanid, and Other Second-Line Drugs. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 10-12, Volume: 75, Issue:8 Topics: Antitubercular Agents; Clofazimine; Cohort Studies; Diarylquinolines; Electrolytes; Fluoroquinolones; Humans; Linezolid; Nitroimidazoles; Oxazoles; Prospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant	2022
Population Pharmacokinetics of Delamanid and its Main Metabolite DM-6705 in Drug-Resistant Tuberculosis Patients Receiving Delamanid Alone or Coadministered with Bedaquiline. Clinical pharmacokinetics, 2022, Volume: 61, Issue:8 Topics: Adult; Albumins; Antitubercular Agents; Diarylquinolines; HIV Infections; Humans; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2022
Discovery and preclinical evaluations of JBD0131, a novel nitrodihydro-imidazooxazole anti-tuberculosis agent. Bioorganic & medicinal chemistry letters, 2022, 09-15, Volume: 72 Topics: Antitubercular Agents; Humans; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2022
[Expert consensus on clinical application of delamanid]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2022, Sep-12, Volume: 45, Issue:9 Topics: Consensus; Humans; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2022
Pediatric delamanid treatment for children with rifampicin-resistant TB. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2022, 10-01, Volume: 26, Issue:10 Topics: Antitubercular Agents; Child; Humans; Nitroimidazoles; Oxazoles; Rifampin; Tuberculosis, Multidrug-Resistant	2022
Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB. Emerging infectious diseases, 2023, Volume: 29, Issue:5 Topics: Antitubercular Agents; Diarylquinolines; Female; Humans; Middle Aged; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2023
The effect of anti-tuberculosis drug pharmacokinetics on QTc prolongation. International journal of antimicrobial agents, 2023, Volume: 62, Issue:4 Topics: Adult; Antitubercular Agents; Diarylquinolines; Female; Humans; Long QT Syndrome; Male; Nitroimidazoles; Oxazoles; Prospective Studies; Tuberculosis, Multidrug-Resistant	2023
The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens. BMC infectious diseases, 2019, Aug-20, Volume: 19, Issue:1 Topics: Antitubercular Agents; Diarylquinolines; Drug Therapy, Combination; Humans; Multicenter Studies as Topic; Nitroimidazoles; Observational Studies as Topic; Oxazoles; Prospective Studies; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2019
A regimen containing bedaquiline and delamanid compared to bedaquiline in patients with drug-resistant tuberculosis. The European respiratory journal, 2020, Volume: 55, Issue:1 Topics: Antitubercular Agents; Diarylquinolines; Humans; Nitroimidazoles; Oxazoles; Prospective Studies; Tuberculosis, Multidrug-Resistant	2020
Culture Conversion at 6 Months in Patients Receiving Delamanid-containing Regimens for the Treatment of Multidrug-resistant Tuberculosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 07-11, Volume: 71, Issue:2 Topics: Antitubercular Agents; Humans; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2020
Clinical Outcomes Among Patients With Drug-resistant Tuberculosis Receiving Bedaquiline- or Delamanid-Containing Regimens. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 12-03, Volume: 71, Issue:9 Topics: Adult; Antitubercular Agents; Diarylquinolines; Female; Georgia; Humans; Male; Nitroimidazoles; Oxazoles; Prospective Studies; Tuberculosis, Multidrug-Resistant	2020
Interim treatment outcomes in multidrug-resistant tuberculosis patients treated sequentially with bedaquiline and delamanid. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 98 Topics: Adult; Aged; Antitubercular Agents; Diarylquinolines; Female; Humans; Male; Middle Aged; Nitroimidazoles; Oxazoles; Retrospective Studies; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult	2020
Correspondence regarding "Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa". The European respiratory journal, 2020, Volume: 56, Issue:1 Topics: Humans; Nitroimidazoles; Oxazoles; Retrospective Studies; Rifampin; South Africa; Tuberculosis, Multidrug-Resistant	2020
Multidrug Resistant Tuberculosis With Simultaneously Acquired Drug Resistance to Bedaquiline and Delamanid. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 12-16, Volume: 73, Issue:12 Topics: Antitubercular Agents; Diarylquinolines; Drug Resistance; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2021
Operational Research on the Treatment of Drug-Resistant Tuberculosis: Exciting Results That Need to Be Protected. American journal of respiratory and critical care medicine, 2021, 01-01, Volume: 203, Issue:1 Topics: Diarylquinolines; Humans; Nitroimidazoles; Operations Research; Oxazoles; Prospective Studies; Tuberculosis, Multidrug-Resistant	2021
Natural Polymorphisms in Mycobacterium tuberculosis Conferring Resistance to Delamanid in Drug-Naive Patients. Antimicrobial agents and chemotherapy, 2020, 10-20, Volume: 64, Issue:11 Topics: Africa; Antitubercular Agents; Asia; Humans; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Pharmaceutical Preparations; South America; Tuberculosis, Multidrug-Resistant	2020
Characterization of Genomic Variants Associated with Resistance to Bedaquiline and Delamanid in Naive Mycobacterium tuberculosis Clinical Strains. Journal of clinical microbiology, 2020, 10-21, Volume: 58, Issue:11 Topics: Antitubercular Agents; Diarylquinolines; Genomics; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2020
Design, synthesis, and evaluation of substituted 2-acylamide-1,3-benzo[d]zole analogues as agents against MDR- and XDR-MTB. European journal of medicinal chemistry, 2021, Jan-01, Volume: 209 Topics: Animals; Antitubercular Agents; Drug Design; Female; Halogenation; HEK293 Cells; Humans; Male; Mice; Mycobacterium tuberculosis; Oxazoles; Rats, Sprague-Dawley; Thiadiazoles; Tuberculosis, Multidrug-Resistant	2021
One Step Forward: Successful End-of-Treatment Outcomes of Patients With Drug-Resistant Tuberculosis Who Received Concomitant Bedaquiline and Delamanid in Mumbai, India. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 11-02, Volume: 73, Issue:9 Topics: Adult; Antitubercular Agents; Diarylquinolines; Female; Humans; India; Nitroimidazoles; Oxazoles; Retrospective Studies; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult	2021
Concurrent use of bedaquiline and delamanid for the treatment of fluoroquinolone-resistant multidrug-resistant tuberculosis: a nationwide cohort study in South Korea. The European respiratory journal, 2021, Volume: 57, Issue:3 Topics: Antitubercular Agents; Cohort Studies; Diarylquinolines; Fluoroquinolones; Humans; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Republic of Korea; Tuberculosis, Multidrug-Resistant	2021
Population Pharmacokinetic Analysis of Delamanid in Patients with Pulmonary Multidrug-Resistant Tuberculosis. Antimicrobial agents and chemotherapy, 2020, 12-16, Volume: 65, Issue:1 Topics: Adolescent; Adult; Antitubercular Agents; Humans; Middle Aged; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult	2020
Compassionate use of delamanid in adults and children for drug-resistant tuberculosis: 5-year update. The European respiratory journal, 2021, Volume: 57, Issue:5 Topics: Adolescent; Adult; Antitubercular Agents; Child; Compassionate Use Trials; Humans; Nitroimidazoles; Oxazoles; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2021
Pharmacokinetics of bedaquiline, delamanid and clofazimine in patients with multidrug-resistant tuberculosis. The Journal of antimicrobial chemotherapy, 2021, 03-12, Volume: 76, Issue:4 Topics: Antitubercular Agents; Clofazimine; Diarylquinolines; Humans; Nitroimidazoles; Oxazoles; Prospective Studies; Tuberculosis, Multidrug-Resistant	2021
Treatment outcomes of children and adolescents receiving drug-resistant TB treatment in a routine TB programme, Mumbai, India. PloS one, 2021, Volume: 16, Issue:2 Topics: Adolescent; Ambulatory Care Facilities; Antitubercular Agents; Child; Child, Preschool; Diarylquinolines; Extensively Drug-Resistant Tuberculosis; Female; Humans; India; Infant; Infant, Newborn; Male; Nitroimidazoles; Oxazoles; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2021
Development and validation of a liquid chromatography-tandem mass spectrometry method for quantifying delamanid and its metabolite in small hair samples. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2021, Apr-15, Volume: 1169 Topics: Chromatography, Liquid; Hair; Humans; Limit of Detection; Linear Models; Nitroimidazoles; Oxazoles; Reproducibility of Results; Tandem Mass Spectrometry; Tuberculosis; Tuberculosis, Multidrug-Resistant	2021
Culture conversion at six months in patients receiving bedaquiline- and delamanid-containing regimens for the treatment of multidrug-resistant tuberculosis. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021, Volume: 113 Suppl 1 Topics: Diarylquinolines; Humans; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2021
Outcomes of Multidrug-Resistant Tuberculosis Treated With Bedaquiline or Delamanid. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 10-20, Volume: 73, Issue:8 Topics: Antitubercular Agents; Cohort Studies; Diarylquinolines; Humans; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2021
Outcomes of Children Born to Pregnant Women With Drug-resistant Tuberculosis Treated With Novel Drugs in Khayelitsha, South Africa: A Report of Five Patients. The Pediatric infectious disease journal, 2021, 05-01, Volume: 40, Issue:5 Topics: Adult; Antitubercular Agents; Child Health; Child, Preschool; Diarylquinolines; Female; Humans; Infant; Infant Health; Linezolid; Nitroimidazoles; Oxazoles; Pregnancy; Pregnancy Outcome; Pregnant Women; South Africa; Tuberculosis, Multidrug-Resistant; Young Adult	2021
Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use. The European respiratory journal, 2017, Volume: 50, Issue:1 Topics: Adolescent; Adult; Antitubercular Agents; Child; Communicable Disease Control; Compassionate Use Trials; Extensively Drug-Resistant Tuberculosis; Female; Global Health; Humans; Male; Middle Aged; Nitroimidazoles; Oxazoles; Treatment Outcome; Tuberculosis, Multidrug-Resistant; World Health Organization	2017
Six-Month Response to Delamanid Treatment in MDR TB Patients. Emerging infectious diseases, 2017, Volume: 23, Issue:10 Topics: Adolescent; Antitubercular Agents; Female; Hepatitis C; HIV Infections; Humans; Male; Nitroimidazoles; Oxazoles; Retrospective Studies; Tuberculosis, Multidrug-Resistant	2017
Clinical significance of QT-prolonging drug use in patients with MDR-TB or NTM disease. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2017, 09-01, Volume: 21, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Azithromycin; Child; Clarithromycin; Clofazimine; Diarylquinolines; Female; Fluoroquinolones; Follow-Up Studies; Humans; Lost to Follow-Up; Macrolides; Male; Middle Aged; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nitroimidazoles; Nontuberculous Mycobacteria; Oxazoles; Retrospective Studies; Tuberculosis, Multidrug-Resistant; Young Adult	2017
Bedaquiline or delamanid for rifampin-resistant tuberculosis? The Lancet. Respiratory medicine, 2017, Volume: 5, Issue:10 Topics: Antitubercular Agents; Diarylquinolines; Drug Resistance, Bacterial; Humans; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Rifampin; Tuberculosis, Multidrug-Resistant	2017
Incorporating social justice and stigma in cost-effectiveness analysis: drug-resistant tuberculosis treatment. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2017, 11-01, Volume: 21, Issue:11 Topics: Antitubercular Agents; Cost-Benefit Analysis; Decision Trees; Diarylquinolines; Humans; Models, Theoretical; Nitroimidazoles; Oxazoles; Social Justice; Social Stigma; South Africa; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2017
Interim outcomes of delamanid for the treatment of MDR- and XDR-TB in South Korea. The Journal of antimicrobial chemotherapy, 2018, 02-01, Volume: 73, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Bacteriological Techniques; Drug-Related Side Effects and Adverse Reactions; Female; Hospitals; Humans; Male; Middle Aged; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Republic of Korea; Retrospective Studies; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult	2018
Final treatment outcomes of multidrug- and extensively drug-resistant tuberculosis patients in Latvia receiving delamanid-containing regimens. The European respiratory journal, 2017, Volume: 50, Issue:5 Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Extensively Drug-Resistant Tuberculosis; Female; Humans; Latvia; Male; Middle Aged; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Retrospective Studies; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult	2017
World Health Organization recommendations for multidrug-resistant tuberculosis: should different standards be applied? The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2017, 12-01, Volume: 21, Issue:12 Topics: Antitubercular Agents; Diarylquinolines; Drug Administration Schedule; Humans; Nitroimidazoles; Oxazoles; Practice Guidelines as Topic; Tuberculosis, Multidrug-Resistant; World Health Organization	2017
Safety and efficacy of exposure to bedaquiline-delamanid in multidrug-resistant tuberculosis: a case series from France and Latvia. The European respiratory journal, 2018, Volume: 51, Issue:3 Topics: Adult; Antitubercular Agents; Clinical Trials as Topic; Diarylquinolines; Drug Administration Schedule; France; Humans; Latvia; Male; Nitroimidazoles; Oxazoles; Patient Safety; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2018
Combining bedaquiline and delamanid to treat multidrug-resistant tuberculosis. The Lancet. Infectious diseases, 2018, Volume: 18, Issue:5 Topics: Armenia; Diarylquinolines; Humans; India; Nitroimidazoles; Oxazoles; Retrospective Studies; South Africa; Tuberculosis, Multidrug-Resistant	2018
Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study. The Lancet. Infectious diseases, 2018, Volume: 18, Issue:5 Topics: Adult; Antitubercular Agents; Armenia; Arrhythmias, Cardiac; Cohort Studies; Diarylquinolines; Drug Therapy, Combination; HIV Infections; Humans; India; Nitroimidazoles; Oxazoles; Retrospective Studies; South Africa; Tuberculosis, Multidrug-Resistant	2018
Bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis: a multicentre cohort study in Korea. The European respiratory journal, 2018, Volume: 51, Issue:3 Topics: Adult; Antitubercular Agents; Cohort Studies; Diarylquinolines; Drug Administration Schedule; Female; Geography; Humans; Male; Middle Aged; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Republic of Korea; Tuberculosis, Multidrug-Resistant; World Health Organization	2018
Using new TB tools: global rhetoric and ground reality. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2018, 04-01, Volume: 22, Issue:4 Topics: Diarylquinolines; Humans; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2018
Global programmatic use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2018, 04-01, Volume: 22, Issue:4 Topics: Antitubercular Agents; Diarylquinolines; Humans; Internationality; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2018
The World Health Organization global aDSM database: generating evidence on the safety of new treatment regimens for drug-resistant tuberculosis. The European respiratory journal, 2018, Volume: 51, Issue:3 Topics: Antitubercular Agents; Communicable Disease Control; Databases, Factual; Diarylquinolines; Humans; Infectious Disease Medicine; Isoniazid; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Patient Safety; Public Health; Rifampin; Tuberculosis, Multidrug-Resistant; World Health Organization	2018
Will regulatory issues continue to be a major barrier to access to bedaquiline and delamanid? The European respiratory journal, 2018, Volume: 51, Issue:3 Topics: Antitubercular Agents; Diarylquinolines; Diffusion of Innovation; Drug and Narcotic Control; Drug Approval; Global Health; Health Services Accessibility; Humans; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2018
Early experience with delamanid-containing regimens in the treatment of complicated multidrug-resistant tuberculosis in Hong Kong. The European respiratory journal, 2018, Volume: 51, Issue:6 Topics: Adult; Antitubercular Agents; Female; Hong Kong; Humans; Male; Middle Aged; Nitroimidazoles; Oxazoles; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2018
Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa. The European respiratory journal, 2018, Volume: 51, Issue:6 Topics: Adult; Antitubercular Agents; Female; Humans; Logistic Models; Male; Nitroimidazoles; Oxazoles; Retrospective Studies; Rifampin; South Africa; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2018
QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: a Tuberculosis Network European Trialsgroup (TBnet) study. The European respiratory journal, 2018, Volume: 52, Issue:2 Topics: Antitubercular Agents; Cardiotoxicity; Cross-Sectional Studies; Diarylquinolines; Electrocardiography; Europe; Humans; Internationality; Long QT Syndrome; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2018
Validating a 14-Drug Microtiter Plate Containing Bedaquiline and Delamanid for Large-Scale Research Susceptibility Testing of Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:9 Topics: Antitubercular Agents; Clofazimine; Diarylquinolines; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Reproducibility of Results; Tuberculosis; Tuberculosis, Multidrug-Resistant	2018
Delamanid, Bedaquiline, and Linezolid Minimum Inhibitory Concentration Distributions and Resistance-related Gene Mutations in Multidrug-resistant and Extensively Drug-resistant Tuberculosis in Korea. Annals of laboratory medicine, 2018, Volume: 38, Issue:6 Topics: Antitubercular Agents; Diarylquinolines; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Republic of Korea; Tuberculosis, Multidrug-Resistant	2018
Cost-effectiveness of bedaquiline or delamanid plus background regimen for multidrug-resistant tuberculosis in a high-income intermediate burden city of China. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2019, Volume: 78 Topics: Adult; Cost-Benefit Analysis; Diarylquinolines; Follow-Up Studies; Hong Kong; Humans; Middle Aged; Monte Carlo Method; Nitroimidazoles; Oxazoles; Quality-Adjusted Life Years; Retrospective Studies; Socioeconomic Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2019
Compassionate use of delamanid in combination with bedaquiline for the treatment of multidrug-resistant tuberculosis. The European respiratory journal, 2019, Volume: 53, Issue:1 Topics: Adolescent; Adult; Antitubercular Agents; Child; Compassionate Use Trials; Diarylquinolines; Drug Therapy, Combination; Female; HIV Infections; Humans; Internationality; Male; Middle Aged; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant; Young Adult	2019
Delamanid: does it have a role in tuberculosis treatment? The Lancet. Respiratory medicine, 2019, Volume: 7, Issue:3 Topics: Double-Blind Method; Humans; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2019
Delamanid (Deltyba°) and multidrug-resistant pulmonary tuberculosis. Prescrire international, 2017, Volume: 26, Issue:181 Topics: Antitubercular Agents; Electrocardiography; Humans; Long QT Syndrome; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2017
Journey of tuberculosis control in India. The Indian journal of tuberculosis, 2019, Volume: 66, Issue:1 Topics: Antitubercular Agents; Diarylquinolines; Directly Observed Therapy; Goals; History, 20th Century; History, 21st Century; Humans; India; National Health Programs; Nitroimidazoles; Oxazoles; Practice Guidelines as Topic; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2019
Early efficacy and safety of Bedaquiline and Delamanid given together in a "Salvage Regimen" for treatment of drug-resistant tuberculosis. The Indian journal of tuberculosis, 2019, Volume: 66, Issue:1 Topics: Adult; Cardiotoxicity; Clofazimine; Diarylquinolines; Drug Therapy, Combination; Electrocardiography; Female; Humans; Imipenem; Male; Moxifloxacin; Nitroimidazoles; Oxazoles; Salvage Therapy; Sputum; Survival Rate; Tuberculosis, Multidrug-Resistant; Young Adult	2019
The STREAM trial: missed opportunities and lessons for future clinical trials. The Lancet. Infectious diseases, 2019, Volume: 19, Issue:4 Topics: Antitubercular Agents; Deafness; Diarylquinolines; Humans; Nitroimidazoles; Oxazoles; Randomized Controlled Trials as Topic; Research Design; Time Factors; Tuberculosis, Multidrug-Resistant	2019
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2019, Volume: 83 Topics: Antitubercular Agents; Diarylquinolines; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Male; Nitroimidazoles; Oxazoles; Pilot Projects; Tuberculosis; Tuberculosis, Multidrug-Resistant; World Health Organization	2019
Bedaquiline and delamanid in combination for treatment of drug-resistant tuberculosis. The Lancet. Infectious diseases, 2019, Volume: 19, Issue:5 Topics: Antitubercular Agents; Cohort Studies; Diarylquinolines; Drug Therapy, Combination; Humans; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2019
In vitro interaction profiles of the new antitubercular drugs bedaquiline and delamanid with moxifloxacin against clinical Mycobacterium tuberculosis isolates. Journal of global antimicrobial resistance, 2019, Volume: 19 Topics: Antitubercular Agents; Diarylquinolines; Drug Resistance, Multiple, Bacterial; Drug Synergism; Extensively Drug-Resistant Tuberculosis; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Nitroimidazoles; Oxazines; Oxazoles; Tuberculosis, Multidrug-Resistant; Xanthenes	2019
Final treatment outcomes of delamanid-containing regimens in patients with MDR-/XDR-TB in South Korea. The European respiratory journal, 2019, Volume: 54, Issue:5 Topics: Adult; Extensively Drug-Resistant Tuberculosis; Female; Humans; Male; Middle Aged; Nitroimidazoles; Oxazoles; Republic of Korea; Retrospective Studies; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult	2019
Undergraduate Medical Teaching: Time to integrate? The Journal of the Association of Physicians of India, 2018, Volume: 66, Issue:8 Topics: Antitubercular Agents; Drug Approval; Education, Medical; Humans; India; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2018
Current Status of Delamanid in the Management of MDR Tuberculosis. The Journal of the Association of Physicians of India, 2018, Volume: 66, Issue:7 Topics: Antitubercular Agents; Child; Female; Humans; India; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Pregnancy; Tuberculosis, Multidrug-Resistant	2018
Delamanid Central Nervous System Pharmacokinetics in Tuberculous Meningitis in Rabbits and Humans. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:10 Topics: Animals; Antitubercular Agents; Central Nervous System; Female; Humans; Male; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Rabbits; Treatment Outcome; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant	2019
Principles for designing future regimens for multidrug-resistant tuberculosis. Bulletin of the World Health Organization, 2014, Jan-01, Volume: 92, Issue:1 Topics: Antitubercular Agents; Clinical Trials as Topic; Diarylquinolines; Drug Approval; Drug Design; Drug Resistance, Multiple, Bacterial; Humans; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2014
Drug-resistance mechanisms and tuberculosis drugs. Lancet (London, England), 2015, Jan-24, Volume: 385, Issue:9965 Topics: Antitubercular Agents; Diarylquinolines; Drug Approval; Humans; Mutation; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2015
Cost effectiveness of treating multi-drug resistant tuberculosis by adding Deltyba™ to background regimens in Germany. Respiratory medicine, 2015, Volume: 109, Issue:5 Topics: Adult; Antitubercular Agents; Cost-Benefit Analysis; Drug Costs; Female; Germany; Humans; Male; Markov Chains; Nitroimidazoles; Oxazoles; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Treatment Failure; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2015
Determination of MIC distribution and epidemiological cutoff values for bedaquiline and delamanid in Mycobacterium tuberculosis using the MGIT 960 system equipped with TB eXiST. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:7 Topics: Antitubercular Agents; Diarylquinolines; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Reference Values; Tuberculosis; Tuberculosis, Multidrug-Resistant	2015
Classification of antituberculosis drugs: a new proposal based on the most recent evidence. The European respiratory journal, 2015, Volume: 46, Issue:4 Topics: Antitubercular Agents; Carbapenems; Clavulanic Acid; Clofazimine; Diarylquinolines; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Humans; Infectious Disease Medicine; Linezolid; Nitroimidazoles; Oxazoles; Practice Guidelines as Topic; Tuberculosis, Multidrug-Resistant; World Health Organization	2015
Cost-effectiveness of incorporating bedaquiline into a treatment regimen for MDR/XDR-TB in Germany. The European respiratory journal, 2015, Volume: 46, Issue:6 Topics: Antitubercular Agents; Computer Simulation; Cost-Benefit Analysis; Diarylquinolines; Drug Costs; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Germany; Humans; Markov Chains; Models, Economic; Nitroimidazoles; Oxazoles; Pyrazinamide; Tuberculosis, Multidrug-Resistant	2015
Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis. The New England journal of medicine, 2015, Nov-12, Volume: 373, Issue:20 Topics: Antitubercular Agents; Diarylquinolines; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Male; Mutation; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2015
Barriers to new drug development in respiratory disease. The European respiratory journal, 2016, Volume: 47, Issue:1 Topics: Antitubercular Agents; Awards and Prizes; Diarylquinolines; Drug Discovery; Extensively Drug-Resistant Tuberculosis; Humans; Motivation; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2016
Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2016, Volume: 20, Issue:2 Topics: Adult; Antitubercular Agents; Bacterial Load; Diarylquinolines; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Eswatini; Female; Humans; Kenya; Logistic Models; Male; Middle Aged; Multivariate Analysis; Mycobacterium tuberculosis; Nitroimidazoles; Odds Ratio; Oxazoles; Patient Selection; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; USSR; Young Adult	2016
Reciprocity and Ethical Tuberculosis Treatment and Control. Journal of bioethical inquiry, 2016, Volume: 13, Issue:1 Topics: Antitubercular Agents; Beneficence; Communicable Disease Control; Congresses as Topic; Diarylquinolines; Directly Observed Therapy; Ethical Analysis; Ethical Theory; Global Health; Humans; Moral Obligations; Nitroimidazoles; Oxazoles; Patient Isolation; Personal Autonomy; Pharmacovigilance; Poverty; Public Health; Social Justice; Social Responsibility; Tuberculosis, Laryngeal; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Virtues	2016
[New antitubercular agents are not where where we need them to be]. Revue medicale suisse, 2015, Dec-16, Volume: 11, Issue:499 Topics: Antitubercular Agents; Developing Countries; Diarylquinolines; Health Services Accessibility; Humans; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2015
Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis. Emerging infectious diseases, 2016, Volume: 22, Issue:3 Topics: Antitubercular Agents; Diarylquinolines; Drug Approval; Humans; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2016
Global Introduction of New Multidrug-Resistant Tuberculosis Drugs-Balancing Regulation with Urgent Patient Needs. Emerging infectious diseases, 2016, Volume: 22, Issue:3 Topics: Antitubercular Agents; Diarylquinolines; Drug Prescriptions; Drug Resistance, Bacterial; Drug Utilization; Humans; Legislation, Drug; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2016
Antitubercular Agent Delamanid and Metabolites as Substrates and Inhibitors of ABC and Solute Carrier Transporters. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6 Topics: Animals; Antitubercular Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport, Active; Cell Line; Drug Interactions; HEK293 Cells; Humans; Kidney Tubules, Proximal; Neoplasm Proteins; Nitroimidazoles; Octamer Transcription Factor-1; Organic Anion Transporters; Oxazoles; Solute Carrier Proteins; Swine; Tuberculosis, Multidrug-Resistant	2016
Access to new drugs and the global drug-resistant TB crisis: a case series from KwaZulu-Natal, South Africa. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2016, Volume: 20, Issue:7 Topics: Adult; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Health Services Accessibility; Humans; Male; Nitroimidazoles; Oxazoles; South Africa; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult	2016
Mefloquine and its oxazolidine derivative compound are active against drug-resistant Mycobacterium tuberculosis strains and in a murine model of tuberculosis infection. International journal of antimicrobial agents, 2016, Volume: 48, Issue:2 Topics: Animals; Antitubercular Agents; Bacterial Load; Disease Models, Animal; Drug Interactions; Drug Repositioning; Male; Mefloquine; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazoles; Tuberculosis, Multidrug-Resistant	2016
Comparison of Effectiveness Between Delamanid and Bedaquiline Among Patients with Multidrug-Resistant Tuberculosis: A Markov Model Simulation Study. Clinical drug investigation, 2016, Volume: 36, Issue:11 Topics: Aged; Diarylquinolines; Female; Humans; Male; Middle Aged; Nitroimidazoles; Oxazoles; Quality-Adjusted Life Years; Tuberculosis, Multidrug-Resistant	2016
A Bayesian response-adaptive trial in tuberculosis: The endTB trial. Clinical trials (London, England), 2017, Volume: 14, Issue:1 Topics: Adaptive Clinical Trials as Topic; Algorithms; Antitubercular Agents; Bayes Theorem; Computer Simulation; Diarylquinolines; Humans; Nitroimidazoles; Oxazoles; Randomized Controlled Trials as Topic; Research Design; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2017
Cardiac safety of extensively drug-resistant tuberculosis regimens including bedaquiline, delamanid and clofazimine. The European respiratory journal, 2016, Volume: 48, Issue:5 Topics: Antitubercular Agents; Clofazimine; Diarylquinolines; Extensively Drug-Resistant Tuberculosis; Humans; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2016
Cardiac safety of extensively drug-resistant tuberculosis regimens including bedaquiline, delamanid and clofazimine. The European respiratory journal, 2016, Volume: 48, Issue:5 Topics: Antitubercular Agents; Clofazimine; Diarylquinolines; Extensively Drug-Resistant Tuberculosis; Humans; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2016
Applicability of the shorter 'Bangladesh regimen' in high multidrug-resistant tuberculosis settings. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2017, Volume: 56 Topics: Antitubercular Agents; Clinical Protocols; Diarylquinolines; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Moxifloxacin; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Pyrazinamide; Tuberculosis, Multidrug-Resistant; World Health Organization	2017
Estimated generic prices for novel treatments for drug-resistant tuberculosis. The Journal of antimicrobial chemotherapy, 2017, 04-01, Volume: 72, Issue:4 Topics: Algorithms; Antitubercular Agents; Commerce; Diarylquinolines; Drug Costs; Drugs, Generic; Fluoroquinolones; Humans; Moxifloxacin; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2017
India plans to expand access to new tuberculosis drug. Lancet (London, England), 2017, 02-18, Volume: 389, Issue:10070 Topics: Antitubercular Agents; Diarylquinolines; Health Services Accessibility; Humans; India; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2017
Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany. BMC health services research, 2017, 03-08, Volume: 17, Issue:1 Topics: Adult; Antitubercular Agents; Clinical Protocols; Clinical Trials as Topic; Cost-Benefit Analysis; Diarylquinolines; Drug Costs; Drug Therapy, Combination; Female; Germany; Humans; Linezolid; Male; Nitroimidazoles; Observational Studies as Topic; Oxazoles; Quality-Adjusted Life Years; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2017
Confronting multidrug-resistant tuberculosis. The New England journal of medicine, 2012, Jun-07, Volume: 366, Issue:23 Topics: Antitubercular Agents; Epidemics; Female; Humans; Male; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2012
Trial watch: Novel antimicrobial fights TB resistance. Nature reviews. Drug discovery, 2012, Volume: 11, Issue:8 Topics: Antitubercular Agents; Clinical Trials, Phase II as Topic; Drug Design; Humans; Medication Adherence; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2012
Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis. The European respiratory journal, 2013, Volume: 41, Issue:6 Topics: Adolescent; Adult; Antitubercular Agents; Drug Administration Schedule; Extensively Drug-Resistant Tuberculosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nitroimidazoles; Oxazoles; Randomized Controlled Trials as Topic; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult	2013
Multidrug-resistant tuberculosis. The New England journal of medicine, 2012, 11-29, Volume: 367, Issue:22 Topics: Antitubercular Agents; Epidemics; Female; Humans; Male; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2012
Multidrug-resistant tuberculosis. The New England journal of medicine, 2012, 11-29, Volume: 367, Issue:22 Topics: Antitubercular Agents; Epidemics; Female; Humans; Male; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2012
Multidrug-resistant tuberculosis. The New England journal of medicine, 2012, 11-29, Volume: 367, Issue:22 Topics: Antitubercular Agents; Epidemics; Female; Humans; Male; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant	2012